Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Advasa Holdings, Inc.ADBT · Entity 9245 | Director | August 11, 2026 | August 11, 2026 |
| Alaunos Therapeutics, Inc.TCRT · Entity 8339 | Vice President of Finance | August 18, 2025 | August 20, 2025 |
| HeartCore Enterprises, Inc.HTCR · Entity 8377 | Director | February 09, 2022 | February 09, 2022 |
| Sadot Group Inc.GRIL · Entity 7645 | Chief Accounting Officer | May 02, 2022 | May 04, 2022 |
| Streamex Corp.STEX · Entity 1816 | CFO | November 18, 2025 | November 21, 2025 |
| rYojbaba Co., Ltd.RYOJ · Entity 7052 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Advasa Holdings, Inc.
Report date August 11, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.00001SEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Alaunos Therapeutics, Inc.
Report date August 18, 2025 · Filed August 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,775 |
Reported balance
After 2025-08-18 transaction · row 1
1 source rowRow 1 · 2025-08-18 · Grant · Acquired 10,775 · Balance 10,775 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.32 · Expires 2035-08-17 | Direct | 4,000 |
Reported balance
After 2025-08-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-18 · Grant · Acquired 4,000 · Balance 4,000 F1: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date.
HeartCore Enterprises, Inc.
Report date February 09, 2022 · Filed February 09, 2022
This filing explicitly reported no securities owned.
Sadot Group Inc.
Report date May 02, 2022 · Filed May 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.41 · Expires 2032-05-02 | Direct | 25,000 |
Reported balance
After 2022-05-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-02 · Grant · Acquired 25,000 · Balance 25,000 F1: Pursuant to the terms of the employment agreement, the executive was granted a stock option to acquire 25,000 shares of common stock with respect one twentieth of such shares on each of the twenty quarterly anniversaries of the last date of each quarter commencing June 30, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the employment agreement, the executive was granted a stock option to acquire 25,000 shares of common stock with respect one twentieth of such shares on each of the twenty quarterly anniversaries of the last date of each quarter commencing June 30, 2022.
Streamex Corp.
Report date November 18, 2025 · Filed November 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 295,000 |
Reported balance
After 2025-11-18 transaction · row 1
1 source rowRow 1 · 2025-11-18 · Grant · Acquired 60,000 · Balance 295,000 F1: The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant.
rYojbaba Co., Ltd.
Report date March 18, 2026 · Filed March 18, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2025 Filed Nov 21, 2025 21:35 UTC | Streamex Corp. STEX · Entity 1816 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-024659 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,000 F1 · price: The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 23:54 UTC | Alaunos Therapeutics, Inc. TCRT · Entity 8339 | GrantEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0000950170-25-110531 · ownership.xml · derivative · entry 2 Groenewald Ferdinand · CIK 0001734018 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2035-08-17 F1 · derivative.exercise_date: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 23:54 UTC | Alaunos Therapeutics, Inc. TCRT · Entity 8339 | GrantCommon Stock | 10,775 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-110531 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,775 Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 21:30 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013287 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,000 F1 · price: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of May 29, 2025 (the "Date of Grant"), based on a closing price of $5.05 per share on such date. Read SEC document |
| April 24, 2025 Filed Apr 29, 2025 10:28 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-006566 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 F1 · price: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of April 24, 2025 (the "Date of Grant"), based on a closing price of $0.84 per share on such date. Read SEC document |
| March 29, 2025 Filed Apr 1, 2025 20:05 UTC | Alaunos Therapeutics, Inc. TCRT · Entity 8339 | GrantEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000950170-25-048491 · ownership.xml · derivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · VP, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2035-03-28 F1 · derivative.exercise_date: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 29, 2025, with the first vesting occurring on June 29, 2025 subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:35 UTC | Alaunos Therapeutics, Inc. TCRT · Entity 8339 | GrantEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0000950170-24-098103 · ownership.xml · derivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · VP, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2034-08-13 F1 · derivative.exercise_date: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 14, 2024, with the first vesting occurring on November 14, 2024 subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 02, 2022 Filed May 4, 2022 12:30 UTC | Sadot Group Inc. GRIL · Entity 7645 | GrantStock Options · Derivative | 25,000 | Not disclosed Strike: $0.41 | Not disclosed |
DisclosureSEC source: 0001493152-22-012011 · ownership.xml · derivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-05-02 F1 · price: Pursuant to the terms of the employment agreement, the executive was granted a stock option to acquire 25,000 shares of common stock with respect one twentieth of such shares on each of the twenty quarterly anniversaries of the last date of each quarter commencing June 30, 2022. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 21:28 UTC | Sadot Group Inc. GRIL · Entity 7645 | SaleCommon Stock | 19,285 | $0.58 | $11,185.30 |
DisclosureSEC source: 0001493152-22-004963 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 11, 2021 Filed Apr 1, 2021 15:38 UTC | Sadot Group Inc. GRIL · Entity 7645 | GrantCommon Stock | 19,285 | $2.87 | $55,347.95 |
DisclosureSEC source: 0001493152-21-007665 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,285 Read SEC document |
| July 24, 2020 Filed Sep 8, 2020 14:52 UTC | Sadot Group Inc. GRIL · Entity 7645 | OtherCommon Stock | 19,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017379 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reporting person voluntarily returned the above shares of common stock to the company for cancellation. Read SEC document |
| April 18, 2020 Filed May 15, 2020 18:00 UTC | Sadot Group Inc. GRIL · Entity 7645 | GrantCommon Stock | 3,571 | $5.00 | $17,855.00 |
DisclosureSEC source: 0001493152-20-009016 · ownership.xml · nonDerivative · entry 2 Groenewald Ferdinand · CIK 0001734018 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Read SEC document |
| April 18, 2020 Filed May 15, 2020 18:00 UTC | Sadot Group Inc. GRIL · Entity 7645 | GrantCommon Stock | 15,714 | $5.00 | $78,570.00 |
DisclosureSEC source: 0001493152-20-009016 · ownership.xml · nonDerivative · entry 1 Groenewald Ferdinand · CIK 0001734018 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,285 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.